ContributorsPublishersAdvertisers

EP. 3: Management of Extensive-Stage Small Cell Lung Cancer Treatment-Related Events

targetedonc.com
 2021-11-22

Cover picture for the articleThis article reviews the impact of chemotherapy-induced myelosuppression associated with current standard-of-care management of extensive-stage small cell lung cancer and examines new and emerging therapies that may have the potential to address unmet needs. Current Management of Chemotherapy-Induced Myelosuppression. Patients with extensive-stage small cell lung cancer (ES-SCLC) receiving standard-of-care...

www.targetedonc.com

Comments / 0

Comments / 0